| __timestamp | Lantheus Holdings, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 2242216 |
| Thursday, January 1, 2015 | 14358000 | 4536244 |
| Friday, January 1, 2016 | 12203000 | 5184803 |
| Sunday, January 1, 2017 | 18125000 | 3068742 |
| Monday, January 1, 2018 | 17071000 | 7178000 |
| Tuesday, January 1, 2019 | 20018000 | 16267000 |
| Wednesday, January 1, 2020 | 32788000 | 23191000 |
| Friday, January 1, 2021 | 44966000 | 21453000 |
| Saturday, January 1, 2022 | 311681000 | 15265000 |
| Sunday, January 1, 2023 | 77707000 | 25189000 |
Unlocking the unknown
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. have shown distinct strategies in their R&D allocations over the past decade.
From 2014 to 2023, Lantheus Holdings has significantly ramped up its R&D investments, peaking in 2022 with a staggering 2,180% increase compared to 2014. This surge underscores their commitment to advancing medical imaging and therapeutic solutions.
Conversely, Soleno Therapeutics has maintained a more consistent R&D expenditure, with a notable 1,025% increase from 2014 to 2023. Their focus remains on developing treatments for rare diseases, reflecting a steady yet strategic approach.
These contrasting strategies highlight the diverse paths companies take in the pursuit of innovation, each tailored to their unique market positions and long-term goals.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Soleno Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: argenx SE vs Soleno Therapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Lantheus Holdings, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Lantheus Holdings, Inc. and Alpine Immune Sciences, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Research and Development Investment: TG Therapeutics, Inc. vs Soleno Therapeutics, Inc.
HUTCHMED (China) Limited vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending